Drug Profile
LY 517717
Alternative Names: LY517717Latest Information Update: 06 Apr 2011
Price :
$50
*
At a glance
- Originator Amgen
- Developer Amgen; Eli Lilly and Company
- Class Anticoagulants; Antithrombotics; Piperazines
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Stroke; Thromboembolism; Thrombosis